Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Elexacafator/tezacaftor/ivacaftor resolves subfertility in females with CF: A two center case series

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2020.12.011Source: DataRank Database

Elexacafator/tezacaftor/ivacaftor resolves subfertility in females with CF: A two center case series is a research paper published in Journal of Cystic Fibrosis (2021). On theSindex it has a DataRank of 0. It has been cited 65 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access65 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.91)OA: bronzeTopics (47)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Dana L. Goodwin,A Nesmith,Bryan Garcia ORCID,Christina Mingora ORCID,Sigrid Ladores ORCID

Live enrichment

PubMed:33353860 PMC:PMC9101452 OpenAlex:https://openalex.org/W3117674922

National Institutes of Health

Grant: 1K08HL138153-01A1

Functional Categorization of Ciliary Motion in PCD

National Institutes of Health

Grant: 2P30DK072482-12

UAB CF Research and Translation Core Center

NHLBI NIH HHS

Grant: K08 HL138153

NIDDK NIH HHS

Grant: P30 DK072482

FWCI

6.91

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttps://www.cysticfibrosisjournal.com/article/S1569-1993(20)30943-7/pdf

publisherhttps://www.cysticfibrosisjournal.com/article/S1569-1993(20)30943-7/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1569199320309437?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1569199320309437?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jcf.2020.12.011

Fields of Study

Cystic Fibrosis Research Advances03 medical and health sciences0302 clinical medicine

MeSH Terms

AminophenolsCystic FibrosisDrug CombinationsFemaleHumansIndolesInfertilityPregnancyPyrazolesPyridinesPyrrolidinesRetrospective StudiesQuinolonesPregnancy RateBenzodioxolesChloride Channel Agonists

Keywords

IvacaftorMedicineInfertilityCystic fibrosisFertilityAssisted reproductive technologyGynecologyReproductive technologyObstetricsPopulationPregnancyCystic fibrosis transmembrane conductance regulatorInternal medicineGeneticsCftr ModulatorsIndolesPyrrolidinesPregnancy RatePyridinesQuinolonesAminophenolsDrug CombinationsHumansPyrazolesFemaleBenzodioxolesChloride Channel AgonistsRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (2)

Pregnancy in People With Cystic Fibrosis Treated With Highly Effective Modulator Therapy

N/A

0.664DataRank · unranked

Obstetrics and Gynecology(2024)

co-cited

10.1097/aog.0000000000005732

Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models

Clinical Pharmacology & Therapeutics(2025)

co-cited

10.1002/cpt.3705